Posology: The dose is one drop of Olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary.
Use in elderly: No dosage adjustment in elderly patients is necessary.
Paediatric patients: Olopatadine may be used in paediatric patients three years of age and older at the same dose as in adults. The safety and efficacy of Olopatadine in children aged under 3 years has not been established. No data are available.
Use in hepatic and renal impairment: Olopatadine in the form of eye drops has not yet been studied in patients with renal or hepatic disease. However, no dosage adjustment is expected to be necessary in hepatic or renal impairment.
Method of administration: For ocular use only.
After the bottle cap is removed, if the tamper evident snap collar is loose, remove before using the product. To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas, or other surfaces with the dropper tip of the bottle. Keep the bottle tightly closed when not in use.
In case of concomitant therapy with other topical ocular medicines, an interval of five minutes should be allowed between successive applications. Eye ointments should be administered last.
Other Services
Country
Support
Account
Sign Out